These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 24321005)
1. CPP-115, a vigabatrin analogue, decreases spasms in the multiple-hit rat model of infantile spasms. Briggs SW; Mowrey W; Hall CB; Galanopoulou AS Epilepsia; 2014 Jan; 55(1):94-102. PubMed ID: 24321005 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of the galanin analog NAX 5055 in the multiple-hit rat model of symptomatic infantile spasms. Jequier Gygax M; Klein BD; White HS; Kim M; Galanopoulou AS Epilepsy Res; 2014 Jan; 108(1):98-108. PubMed ID: 24252685 [TBL] [Abstract][Full Text] [Related]
3. Carisbamate acutely suppresses spasms in a rat model of symptomatic infantile spasms. Ono T; Moshé SL; Galanopoulou AS Epilepsia; 2011 Sep; 52(9):1678-84. PubMed ID: 21770922 [TBL] [Abstract][Full Text] [Related]
4. Preclinical Screening for Treatments for Infantile Spasms in the Multiple Hit Rat Model of Infantile Spasms: An Update. Galanopoulou AS; Mowrey WB; Liu W; Li Q; Shandra O; Moshé SL Neurochem Res; 2017 Jul; 42(7):1949-1961. PubMed ID: 28462453 [TBL] [Abstract][Full Text] [Related]
5. Vigabatrin therapy implicates neocortical high frequency oscillations in an animal model of infantile spasms. Frost JD; Le JT; Lee CL; Ballester-Rosado C; Hrachovy RA; Swann JW Neurobiol Dis; 2015 Oct; 82():1-11. PubMed ID: 26026423 [TBL] [Abstract][Full Text] [Related]
6. The 2011 E. B. Hershberg award for important discoveries in medicinally active substances: (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115), a GABA aminotransferase inactivator and new treatment for drug addiction and infantile spasms. Silverman RB J Med Chem; 2012 Jan; 55(2):567-75. PubMed ID: 22168767 [No Abstract] [Full Text] [Related]
7. Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial. O'Callaghan FJ; Edwards SW; Alber FD; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay M; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP; Lancet Neurol; 2017 Jan; 16(1):33-42. PubMed ID: 27838190 [TBL] [Abstract][Full Text] [Related]
9. Validation of the rat model of cryptogenic infantile spasms. Chachua T; Yum MS; Velíšková J; Velíšek L Epilepsia; 2011 Sep; 52(9):1666-77. PubMed ID: 21854372 [TBL] [Abstract][Full Text] [Related]
10. Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial. O'Callaghan FJK; Edwards SW; Alber FD; Cortina Borja M; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay MT; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP; Lancet Child Adolesc Health; 2018 Oct; 2(10):715-725. PubMed ID: 30236380 [TBL] [Abstract][Full Text] [Related]
11. Vigabatrin and high-dose prednisolone therapy for patients with West syndrome. Ko A; Youn SE; Chung HJ; Kim SH; Lee JS; Kim HD; Kang HC Epilepsy Res; 2018 Sep; 145():127-133. PubMed ID: 29966811 [TBL] [Abstract][Full Text] [Related]
14. Long-term outcome in children with infantile spasms treated with vigabatrin: a cohort of 180 patients. Djuric M; Kravljanac R; Tadic B; Mrlješ-Popovic N; Appleton RE Epilepsia; 2014 Dec; 55(12):1918-25. PubMed ID: 25377998 [TBL] [Abstract][Full Text] [Related]
15. Randomized trial of vigabatrin in patients with infantile spasms. Elterman RD; Shields WD; Mansfield KA; Nakagawa J; Neurology; 2001 Oct; 57(8):1416-21. PubMed ID: 11673582 [TBL] [Abstract][Full Text] [Related]
16. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Chiron C; Dumas C; Jambaqué I; Mumford J; Dulac O Epilepsy Res; 1997 Jan; 26(2):389-95. PubMed ID: 9095401 [TBL] [Abstract][Full Text] [Related]